Philip Polgreen
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity (NCT05474430) | Philip Polgreen | 2021-12-20 |
| The Effects of the CF Carrier State on the Kidneys and Pancreas (NCT05474417) | Philip Polgreen | 2021-12-20 |
| MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes (NCT03193229) | Philip Polgreen | 2017-05-15 |
Track Philip Polgreen automatically
Every clearance here is in the API, with alerts when new ones post.